BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22548396)

  • 1. Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease.
    Mizutani K; Akita Y; Yanagishita T; Kimura M; Tanaka T; Kinoshita Y; Nakano A; Tamada Y; Matsumoto Y; Watanabe D
    Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):142-6. PubMed ID: 22548396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
    Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
    Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease.
    Morton CA; Whitehurst C; Moseley H; McColl JH; Moore JV; Mackie RM
    Br J Dermatol; 1996 Nov; 135(5):766-71. PubMed ID: 8977678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light.
    Yu CH; Lin HP; Chen HM; Yang H; Wang YP; Chiang CP
    Lasers Surg Med; 2009 Nov; 41(9):628-33. PubMed ID: 19816916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease.
    Cai H; Wang YX; Zheng JC; Sun P; Yang ZY; Li YL; Liu XY; Li Q; Liu W
    Lasers Med Sci; 2015 Jul; 30(5):1505-10. PubMed ID: 25899562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
    Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
    Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Photodynamic Therapy for Bowen's Disease Using Plum-Blossom Needling to Augment Drug Delivery.
    Wu Y; Wang P; Zhang L; Wang B; Wang X
    Dermatol Surg; 2018 Dec; 44(12):1516-1524. PubMed ID: 29994952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer.
    Souza CS; Felicio LB; Ferreira J; Kurachi C; Bentley MV; Tedesco AC; Bagnato VS
    Photodiagnosis Photodyn Ther; 2009; 6(3-4):207-13. PubMed ID: 19932453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
    Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
    Babilas P; Kohl E; Maisch T; Bäcker H; Gross B; Branzan AL; Bäumler W; Landthaler M; Karrer S; Szeimies RM
    Br J Dermatol; 2006 Apr; 154(4):712-8. PubMed ID: 16536815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
    Kim HJ; Song KH
    J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
    Park JY; Kim SK; Cho KH; Kim YC
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Chen HM; Chen CT; Yang H; Kuo MY; Kuo YS; Lan WH; Wang YP; Tsai T; Chiang CP
    Oral Oncol; 2004 Jul; 40(6):630-7. PubMed ID: 15063392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch precancerous lesions by topical 5-aminolevulinic acid-mediated photodynamic therapy.
    Hsu YC; Yang DF; Chiang CP; Lee JW; Tseng MK
    Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):310-8. PubMed ID: 23200011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.